Call for Abstract

Scientific Program

8th International Conference on Pulmonology and Critical Care Medicine, will be organized around the theme “Advanced Research and innovative Therapeutics Approaches towards Pulmonary Disorders”

Pulmonary Disorders 2018 is comprised of 19 tracks and 138 sessions designed to offer comprehensive sessions that address current issues in Pulmonary Disorders 2018.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

Track 1:Pulmonary Diseases and Disorders

Pulmonary Disorders is the abnormal conditions of the respiratory system. Abnormal Conditions includes; chest pain, cough, sputum production, dyspnea, hemoptysis, adventitious sounds and stridor. Pulmonary Disorders is often caused by the decrease or compression of air flow paths that impedes air flows in lungs or respiratory system pathways. People with Pulmonary Disorders could have acute respiratory failures, like general anesthesia or infections. 

  • Track 1-1Environmental Pulmonary Diseases
  • Track 1-2Pulmonary edema
  • Track 1-3Pulmonary embolism
  • Track 1-4Pulmonary Fibrosis
  • Track 1-5Pulmonary Hypertension
  • Track 1-6Pulmonary neoplasm
  • Track 1-7Pulmonary-renal syndrome
  • Track 1-8Idiopathic pulmonary hemosiderosis

Track 2:Symptoms and Comorbid

The full form of COPD is chronic obstructive pulmonary disease and this name includes number of pulmonary disease and conditions like chronic bronchitis and emphysema. Its symptoms are usually slow developing symptoms and it shows over a number of time periods or years. Hence, the effected peoples are often not in aware of having this disease.
The people having COPD will be characterized with swelled lungs and narrow respiratory tracks. Thus, the air sacs in lungs get damaged permanently and it cause severe problems in breathing.
 
 
  • Track 2-1Cough in Adults
  • Track 2-2Dyspnea
  • Track 2-3Hemoptysis
  • Track 2-4Hyperventilation Syndrome
  • Track 2-5Solitary Pulmonary Nodule
  • Track 2-6Stridor
  • Track 2-7Vocal Cord Dysfunction
  • Track 2-8Wheezing

Track 3:Pulmonary Function Testing and Diagnosis

A broad range of test which measures the status of wellness of lungs functions and property to exhale and inhale air and the efficiency as well as capability of lungs in transferring Oxygen into blood is collectively known as Pulmonary Function Testing.
The process includes the chest x-ray and physical examinations. Its outcomes often suggest what additional testing may be needed to determine what is causing the person's symptoms and disease. This test includes predominant practice of measuring the lung’s capacity to move and hold air and to exchange oxygen and carbon dioxide in connective tissues of the body. 
 
  • Track 3-1Plain chest x-rays
  • Track 3-2Chest fluoroscopy
  • Track 3-3High resolution CT (HRCT)
  • Track 3-4Helical CT
  • Track 3-5CT angiography
  • Track 3-6Magnetic Resonance Imaging
  • Track 3-7Ultrasonography and Echocardiogram
  • Track 3-8Nuclear Scanning
  • Track 3-9V/Q scanning and Spirometry
  • Track 3-10Lungs PET

Track 4:Acute Bronchitis

Acute bronchitis is a common respiratory disease which is caused by the infection of bronchi with germs or virus.  Infection with virus is more common than infection with germ or bacteria.

Like other pulmonary disorders, acute bronchitis is inflammation of the trachea or windpipe. These wind pipes roles are to deliver airs to the lungs and other connective tissues. 
 
Very often, people do mistakes by assuming chronic bronchitis as acute bronchitis. Hence, it is crucial to distinguish chronic bronchitis from acute bronchitis. However, these diseases normally last for less than a week. But, the cough remain continue for several days and weeks after the inflammation get healed. Till now, it has been reported that the viruses that cause flu and colds also causes acute bronchitis.
  • Track 4-1Symptoms and Signs
  • Track 4-2Cause of Acute bronchitis
  • Track 4-3Diagnosis of Acute bronchitis
  • Track 4-4Prevention of chest cold
  • Track 4-5Treatment of chest cold

Track 5:Asthma and Related Disorders

Asthma is a disease characterized by inflammation, swelling, narrowness and production of extra mucus in the airways of person’s respiratory tracks. It is caused by different types of allergens. Allergens trigger the bronchoconstriction process resulting in difficulties of air passage.  Asthma patients experience chest tightness, cough which is a common in all asthma patients, dyspnea, wheezing and chest tightness. 
 
Many other disorders have been recognised to show similar sign and symptoms like asthma does. Hence, just because y we have symptoms and sign of asthma, does not mean that we have this diseases. Other related disorders to asthma include; Sinusitis, Myocardial ischemia, and Gastroesophageal reflux disease (GERD). 
 
  • Track 5-1Susceptibility genes
  • Track 5-2Environmental factors
  • Track 5-3Reactive airways dysfunction syndrome (RADS)
  • Track 5-4Pathophysiology of Asthm
  • Track 5-5Classification of Asthma
  • Track 5-6Prognosis and Diagnosis
  • Track 5-7Treatment of Asthma

Track 6:Bronchiectasis and Atelectasis

An irreversible widening of the breathing pipes or respiratory airways resulting from damage to the cilia of epidermal is called Bronchiectasis. The severity of bronchiectasis is tested by computed tomography, Chest x-rays and breathing test. People often are given antibiotics and use other measures to suppress and clear the build-up of mucus.  The conditions in which lungs collapse and became airless are called atelectasis. 
 
 
  • Track 6-1Diffuse bronchiectasis
  • Track 6-2Focal bronchiectasis
  • Track 6-3Complications of bronchiectasis
  • Track 6-4Chronic atelectasis
  • Track 6-5Absorption atelectasis
  • Track 6-6Acute exacerbations
  • Track 6-7Diagnosis and Evaluation
  • Track 6-8Treatment of bronchiectasis

Track 7:COPD and Related Disorders

Chronic obstructive lung disease (COPD) is not a single type of respiratory diseases. It is a combination of groups of lungs disease that caused difficult to breath out gas from the lungs. Thus, it often leads to feeling of being tired or shortness of breath.  COPD are often categorised into two major symptoms i.e. emphysema and chronic bronchitis. So, a person having COPD may be facing either chronic bronchitis or emphysema.
COPD symptoms are productive cough and dyspnea. The common signs and symptoms include decreased breath prolonged expiratory phase of respiration, wheezing and sounds.  COPD get severe and may cause pneumothorax, weight loss, frequent acute decompensation episodes and heart failure. It also causes respiratory failure and acute or chronic. 
  • Track 7-1Chronic obstructive bronchitis
  • Track 7-2Emphysema
  • Track 7-3Smoking and inhalational exposures
  • Track 7-4Genetic factors
  • Track 7-5Inflammation and Infection
  • Track 7-6Airflow limitation
  • Track 7-7Alpha-1 Antitrypsin Deficiency
  • Track 7-8Respiratory infection

Track 8:Pulmonary Vascular Disease

Pulmonary vascular disease, heart and blood vessel disease also known as the disease affaecting the blood vessels leading to lungs from heart, it includes number other diseases which are related to atherosclerosis process. Atherosclerosis is the build-up narrows the arteries condition that develops when a substance called plaque builds up in the walls of the arteries in the connected with the heart. 

  • Track 8-1 Heart Valve Problems
  • Track 8-2Heart Attack
  • Track 8-3Arrhythmia
  • Track 8-4Pulmonary arterial hypertension
  • Track 8-5Coronary Angioplasty
  • Track 8-6Pulmonary venous hypertension

Track 9:Diffuse Alveolar Hemorrhage

Diffuse alveolar hemorrhage (DAH) refers to hemorrhage which originates in the pulmonary microvasculature. It is a life threatening respiratory disease. The clinical syndrome of alveolar hemmorrhage is characterized by diffuse pulmonary infiltrates, hypoxemic respiratory failure, falling haematocrit and hemoptysis. 
 
People with alveolar hemorrhage face dyspnea, hemoptysis and cough. The diagnosis and physical exam are quite nonspecific.  Pateinst will make a rapid succession on their pulmonary test.
  • Track 9-1Goodpasture Syndrome
  • Track 9-2Idiopathic pulmonary hemosiderosis
  • Track 9-3Alveolar hemorrhage and Autoimmune disorders
  • Track 9-4Symptoms and signs of Alveolar Hemorrhage
  • Track 9-5Diagnosis and Treatment

Track 10:Environmental Pulmonary Diseases

Environmental pulmonary diseases are caused by inhalation of allergens, dusts, chemicals, environmental pollutants and gases. Thus, it is known for a risk factor for asthma, it is also being recognized as a cause of COPD in non-smoking person.
A patient who has used a respiratory protection device such as masks, quality respirators and non- smoker has been well protected from the Environmental Pulmonary Diseases.  

  • Track 10-1Air Pollution–Related Illness
  • Track 10-2Asbestosis
  • Track 10-3Mesothelioma
  • Track 10-4Beryllium Disease
  • Track 10-5Byssinosis
  • Track 10-6Pneumoconiosis
  • Track 10-7Occupational Asthma
  • Track 10-8Silicosis
  • Track 10-9Irritant Gas Inhalation Injury

Track 11:Lung Diseases

Lung disease is any problem in the lungs that prevents the lungs from working properly. Lungs diseases are categorised into three main types i.e. Lung tissue diseases, Airway diseases and Lung circulation diseases. Airway diseases affect the airways that carry oxygen and other gases into and out of the lungs in the body. They usually cause a narrowing or blockage of the airways. Airway diseases include asthma, emphysema, bronchiectasis, and chronic bronchitis.
  • Track 11-1Lung Diseases Affecting the Airways
  • Track 11-2Lung Diseases Affecting the Air Sacs
  • Track 11-3Empyema
  • Track 11-4Cystic bronchiectasis
  • Track 11-5Lung cancer
  • Track 11-6Tuberculosis (TB)
  • Track 11-7Cryptogenic Organizing Pneumonia (COP)
  • Track 11-8Pulmonary sequestration
  • Track 11-9Sarcoidosis
  • Track 11-10Respiratory Syncytial Virus (RSV)

Track 12:Pleural Effusion

Pleural Effusion is disease causing to increase an abnormal amount of fluid around the lungs i.e. in a thin membrane that lines the surface of the lungs and the inside of the chest wall outside the lungs. Fluid accumulates in the space between the layers of pleura which allows the lungs to move smoothly within the chest cavity during exhaling and inhaling air. Pleural effusions are result many other medical contortions. It has been noted that, most pleural effusions are not so serious; however, they need immediate treatment to avoid problems which can be severe respiratory diseases. 
The heart, kidney and liver disease may cause excessive fluid to accumulate around the lungs. It may be because the body loss its property of handling fluids. The fluid in pleural effusions may from inflammation and damage, such as in autoimmune disease, pneumonia, and many other related disorders.
  • Track 12-1Congestive heart failure
  • Track 12-2Pneumonia
  • Track 12-3Liver disease (cirrhosis)
  • Track 12-4End stage renal disease
  • Track 12-5Nephrotic syndrome
  • Track 12-6Lupus and other autoimmune conditions
  • Track 12-7Sepsis

Track 13:Pulmonary Embolism

A disease which cause blockage of blood vessels, pulmonary artery and blood vessels are known as pulmonary embolism. Like Pleural Effusion, pulmonary embolism symptoms are also difficult to recognise as they are vary from person to person. Common symptoms include; chest pain which is like stabbing pain that may be worse when you breathe in. Shortness of breath developed gradually or comes suddenly.

  • Track 13-1Acute dyspnea
  • Track 13-2Pleuritic chest pain
  • Track 13-3Cough
  • Track 13-4Tachycardia
  • Track 13-5Tachypnea
  • Track 13-6COPD exacerbation
  • Track 13-7Pneumothorax
  • Track 13-8Acute anxiety with hyperventilation

Track 14:Sleep Apnea

Sleep apnea is a sleep disorder characterized by pauses in breathing or instances of shallow breathing.  Apnea is the pauses between breaths. It can last for a few seconds to several minutes i.e. often severe for the body.  And each abnormal shallow breathing event is termed as hypopnea. Sleep apnea has been categorised into three forms i.e. obstructive (OSA), mixed sleep apnea and central sleep apnea (CSA).

  • Track 14-1Obstructive Sleep Apnea
  • Track 14-2Obstructive Sleep Apnea in Children
  • Track 14-3Obstructive Sleep Apnea in Adults
  • Track 14-4Central Sleep Apnea
  • Track 14-5Mixed sleep apnea

Track 15:Pulmonary Research

There is an urgent need of proper and innovative research on pulmonary disorders. It is because, between 3 and 7 million Americans are currently diagnosed with chronic obstructive pulmonary disease (COPD). These people suffer years of progressive discomfort and disability with their respiratory systems. With the number of deaths per year attributed to this disease at approximately 100,000 and increasing thus, COPD is now the fourth leading cause of death in this country and is expected to be third by the year 2020. Cigarette smoking is firmly established as the major cause of COPD, but approximately one-quarter of Americans continue to smoke, despite aggressive smoking prevention and cessation efforts. Better means are clearly needed for the prevention and treatment of COPD, and more scientific research is needed to enable improvements in its clinical management.
Research progress in pulmonary disorders has been slow and inappropriate. The main focus of the basic pulmonary research over the past 40 years has focused on the roles of inflammation, cigarette smoke, and the balance of protease.  However, now there are encouraging indications for future COPD and pulmonary disorders research. Furthermore, the detail study of several cellular pathways that are critically involved in COPD pathogenesis and respiratory disease may lead rapidly to clinical trials of potential therapeutics.
  • Track 15-1Enviromental and Occupational Lungs Disease
  • Track 15-2Genetic base study
  • Track 15-3Lungs and Pulmonary infections
  • Track 15-4Lungs transplantation
  • Track 15-5Pulmonary Immunology
  • Track 15-6Regenrative Medicine
  • Track 15-7Respiratory Epidemiology

Track 16:Pulmonary Rehabilitation

Pulmonary rehabilitation is a program of education, support and exercise to help the people to learn to breath and function at the highest level.  At pulmonary rehabilitation, people learn how to manage your COPD and to stay healthy.
At Pulmonary Rehabilitation, the rehabilitation team talks to the patient’s current level of activity and takes a complete health history. Thus, they set goals to help your for healthy breath and for what is most important. They monitor the patients’ blood pressure and oxygen level and heart beat rate.
  • Track 16-1Education
  • Track 16-2Exercise training
  • Track 16-3Psychosocial interventions
  • Track 16-4Chest physiotherapy
  • Track 16-5Postural drainage
  • Track 16-6Chest percussion technique
  • Track 16-7Hypoxia and aspiration

Track 17:Critical Care Medicine

Critical care medicine envelops the analysis and treatment of a wide assortment of clinical issues represnt to the extreme of  human diseases. Critically sick patients require concentrated care by a planned group. The crical care expert might be the essential supplier of care or a specialist. The intensivist should be skillful not just in a wide scope of conditions normal among critically sick patients additionally with the mechanical systems and gadgets utilized as a part of escalated care settings. The care of critically sick patients additionally raises numerous confused moral and social issues, and the intensivist must be able in ranges, for example, end-of-life choices, propel mandates, evaluating visualization, and guiding of patients and their families.
 

  • Track 17-1Advancement in medical care
  • Track 17-2Diagnosis and management
  • Track 17-3Invasive monitoring
  • Track 17-4Organs and Life Supports
  • Track 17-5Multiple organ failure
  • Track 17-6Cardiovascular system

Track 18:Novel Approach and Therapies

A novel approach is needed in the therapeutics strategy of dealing with air born disease and respiratory problems.  Lungs are exposed to number of airborne pathogen or toxic as it inhale and exhale more than 10,000 litres of air daily. This airway epithelium responds to such exposure by increasing its production of mediators such as cytokines, chemokines and antimicrobial peptides thus, it triggers or activates body immune system to defence pulmonary circulation of body. Recent findings indicate the importance of these peptides as effector molecules of innate immunity by killing microorganisms, but also as regulators of inflammation, immunity and wound repair. 
 
  • Track 18-1Conventional therapies
  • Track 18-2Cytotoxic therapy
  • Track 18-3Antifibrotic therapies
  • Track 18-4Medications
  • Track 18-5Oxygen therapy
  • Track 18-6Vaccinations and Nutrition
  • Track 18-7Lung volume reduction surgery
  • Track 18-8Lung transplantation

Track 19:Technologies and Global Markets

In today’s economic climate your business decisions are as crucial as ever. International Conference on Pulmonology, Pulmonary & Critical Care Medicine allows you to maximize your time and marketing dollars while receiving immediate feedback on your new products and services. International Conference on Pulmonology, Pulmonary & Critical Care Medicine is organizing an outstanding Scientific Exhibition/Program and anticipates the world’s leading specialists involved in.

Pulmonary Disorders 2017 organizing committee anticipates over 300 participants to attend this premier event. Your organization will benefit with excellent exposure to the leaders in Pulmonology.

Pulmonary Disorders 2017 is an exciting opportunity to showcase the new technology, the new products of your company, and/or the service your industry may offer to a broad international audience.
Participant will come to know about the how well their business is using the current marketing techniques. Business Participants will come to know about the progress and results of the past on pulmonary and respiratory market.

Pulmonary Disorders 2017 is also focuses on external and internal factors. Know about the strengths and weaknesses of the current business/company strategies and get clear vision about your business/company on its time and resource in a single platform at Pulmonary Disorders 2017.Get insight into current trends and understand your business, product, service as well as your competitors. Increase you network and take the advantages of B2B meetings at Pulmonary Disorders 2017.

  • Track 19-1Pulmonary and Respiratory Global Markets
  • Track 19-2Key Drugs and Therapeutics
  • Track 19-3Research Scopes and Industry Analysis
  • Track 19-4Market Growth Drivers
  • Track 19-5Factors limiting Market Growth
  • Track 19-6Pricing, Trends and Forecast